Market Size of Europe Contraceptives Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 7.15 % |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Europe Contraceptives Market Analysis
The European contraceptives market is expected to witness a CAGR of 7.15% during the forecast period.
COVID-19 has significantly impacted the European contraceptive market due to the barriers to accessing contraceptives due to supply chain disruption and lockdown restrictions. For instance, the European Parliamentary Forum for Sexual and Reproductive Rights report published in September 2021 stated that 12.5% of Spanish women quit using the hormonal contraceptive pill and discontinued the drug because getting a prescription was difficult during COVID-19 due to the disruption in the healthcare services. This has impacted the market growth leading to a decline in sales of contraceptives in Europe. However, in the current scenario, with the ease of restrictions and availability of all the healthcare services, the demand for contraceptives may grow in European countries, which is expected to drive the growth of the studied market over the forecast period.
The increasing awareness about sexually transmitted diseases (STDs), the rising rate of unintended pregnancies, and increased government initiatives are the major factors driving the market growth. For instance, in November 2021, a report published by European Centre for Disease Prevention and Control stated that the sex between men and women is the second most commonly reported mode of transmission in the European Union, accounting for 29.7% (4,445) of all HIV diagnoses. The highest proportions of these were observed in France, 53.0%. Thus, such instances indicate that the demand for contraceptive devices may increase. Thereby considerable market growth is anticipated over the forecast period.
Moreover, the increasing cases of unintended pregnancies leading to abortions also increase the demand for contraceptives. For instance, an article published by the Journal of Health Monitoring in June 2022 reported that 94,596 abortions were recorded in Germany in 2021. The highest number of abortions was recorded in women aged between 30 and 24. Thus, an increased number of abortions due to unintended pregnancy is driving the demand for contraceptives in the regions, fueling the studied market's growth.
Furthermore, rising approvals from the European Union on oral contraceptives will drive market growth over the forecast period. For instance, in May 2021, European Commission accepted the registration application for the novel combined oral contraceptive Estelle developed by Mithra, a company dedicated to Women's Health. Such approvals will lead to increased adoption of oral contraceptives in Europe due to the rise in the availability of contraceptives in the market.
Thus, due to the increasing prevalence of sexually transmitted diseases (STDs), the growing rate of unintended pregnancies, the increasing demand for modern contraceptive methods, and rising approvals from the European Union for the use of contraceptives, the studied market is expected to witness significant growth over the forecast period. However, factors such as the side effects of contraception and sociocultural issues associated with contraception are expected to hinder market growth.
